{
  "docId": "019de074-80bf-72b8-b7b1-d0f771f9e60f",
  "docSlug": "78e7004510e3b27003e9c94a6172e682",
  "documentTitle": "Chimerix | Investor Presentation Deck | 38 slides",
  "authorId": "chimerix",
  "authorName": "Chimerix",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 33,
  "pageCount": 38,
  "prevPage": 32,
  "nextPage": 34,
  "slideType": "product_demo",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide shows a bioluminescence imaging comparison of tumor burden in mice treated with Vehicle, ONC201, and ONC212.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-80bf-72b8-b7b1-d0f771f9e60f/33",
  "deckHref": "/decks/019de074-80bf-72b8-b7b1-d0f771f9e60f",
  "deckJsonHref": "/decks/019de074-80bf-72b8-b7b1-d0f771f9e60f.json",
  "deckAnchorHref": "/decks/019de074-80bf-72b8-b7b1-d0f771f9e60f#slide-33",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.23,
        "x": 0.62,
        "y": 0.43
      },
      "kind": "image",
      "text": "Bioluminescence imaging of mice treated with Vehicle, ONC201, and ONC212",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36272251-3cda-44d2-8559-e50c2be94079",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.28,
        "w": 0.53,
        "x": 0.04,
        "y": 0.28
      },
      "kind": "list",
      "text": "Distinct molecular target (GPR132) and efficacy profile relative to ONC201/ONC206\nEfficacy in preclinical models of advanced cancers\nGLP-tox studies complete, potential to advance to IND\nPartnerships established for early-stage clinical trials with Brown University and MD Anderson Cancer Center",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "325e7b28-a913-4188-9f5c-815e3ed79c19",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.28,
        "x": 0.59,
        "y": 0.23
      },
      "kind": "paragraph",
      "text": "Pancreatic cancer model shows the potential of ONC212",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "433344b0-de27-4a7d-a368-196317938e3d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.12,
        "x": 0.1,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. Lev et al, Oncotarget 2017",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ac3958c-c04b-4002-a3ff-ad1bf77c100f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.48,
        "x": 0.26,
        "y": 0.06
      },
      "kind": "title",
      "text": "ONC212: GPR132 + ClpP Agonist",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f980d46a-426a-49df-b4a1-a03178c1bef9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "ee414cfa-98ec-4256-8753-a22d1ad85fff",
      "evidence": "preclinical models of advanced cancers",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}